CERBA HEALTHCARE supports the development of MENALABS, a group of medical biology laboratories based in the United Arab Emirates.
CERBA HEALTHCARE, which has its biggest presence in Europe, followed by the USA, Australia, South Africa and China, strengthens its international positions in a region that is experiencing strong growth, with the help of a seasoned management and medical team, in place since the inception of the MENALABS project.CERBA HEALTHCARE subscribed to a capital increase and now holds a majority stake in MENAHOLD, the holding company of MENALABS group. CERBA HEALTHCARE may further support the acquisition and development strategy of MENALABS in the future.
CVML advised MENALABS with Pierre Treille, partner, and Elise Pouron and Pierre Plettener, associates.
Goodwin advised CERBA HEALTHCARE with William Robert, partner, and Chloé VuThien, associate.
About CERBA HEALTHCARE
The group is active in three complementary segments:
- Routine medical biology, mainly in France, Belgium and Luxembourg, with more than 300 laboratories, more than 150 specimen collection centres and 50 technical platforms.
- Specialist medical biology, through its historic laboratory serving more than 50 countries in Europe, Africa and Asia.
- Clinical trial biology – essential in the development process of new molecules by the pharmaceutical and biotechnology industry – through its subsidiaries set up across the five continents.
Recently, CERBA HEALTHCARE diversified into the veterinary biology market through the creation of Cerba Vet.
CERBA HEALTHCARE has approximately 4,200 employees, including 350 biologists. In 2015, its consolidated turnover was EUR 605 million.
MENALABS is a group of medical biology laboratories which was founded in 2014 by a team with more than 20 years of experience in managing laboratories. MENALABS is based in the United Arab Emirates with laboratories in Dubai, Sharjah and Abu Dhabi.The group also recently opened its first veterinary biology laboratory in Sharjah, specialising in equine work.